Camel milk as an alternative treatment regimen for diabetes therapy

• Main Authors: Humaira Hussain, Feroza Hamid Wattoo, Muhammad Hamid Sarwar Wattoo, Muhammad Gulfraz, Tariq Masud, Imam Shah, Sakhawat Ali, Seyed Ebrahim Alavi
• Format: Article
• Language: English
• Published: Wiley 2021-03-01
• Series: Food Science & Nutrition
• Subjects: antidiabetic activity; glibenclamide; hepatoprotective effect; triglyceride
• Online Access: https://doi.org/10.1002/fsn3.2078

Abstract Camel milk is a valuable source of nutrition with a wide range of therapeutic effects. Its unique composition helps to regulate the blood glucose level. The current study is aimed to evaluate the antidiabetic and hepatoprotective effects, as well as lipid profile restoration of camel milk in the diabetic mouse model. This innovative study evaluates the therapeutic effects of camel milk in diabetic mice by simultaneous measurement of blood glucose, HbA1c, ALT, AST, TG, cholesterol, and histopathological studies. The results showed that camel milk has significantly reduced blood glucose, HbA1c (p < .001), aspartate transaminase (AST), alanine transaminase (ALT) (p < .01), triglyceride (TG), and cholesterol (p < .01), compared to that in the diabetic control group. Also, the therapeutic effects of camel milk were completely comparable with the antidiabetic drug glibenclamide. The results of this study suggest that camel milk could be used as a proper alternative treatment regimen for diabetes therapy.